Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc.verified

SGMO

Price:

$2.39

Market Cap:

$498.67M

Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used in modifying DNA sequences by adding or knocking out specific genes; and ZFP transcription factors proteins used in increasing or decreasing gene expression. It develops SB-525, which is in Phase III AFFINE clinical trial for the treatment of hemophilia A; ST-920, a gene therapy, which is in Phase I/II STAAR clinical tria...[Read more]

Industry

Biotechnology

IPO Date

2000-04-06

Stock Exchange

NASDAQ

Ticker

SGMO

The Enterprise Value as of December 2024 (TTM) for Sangamo Therapeutics, Inc. (SGMO) is 487.19M

According to Sangamo Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 487.19M. This represents a change of 372.95% compared to the average of 103.01M of the last 4 quarters.

Sangamo Therapeutics, Inc. (SGMO) Historical Enterprise Value (quarterly & annually)

How has SGMO Enterprise Value performed in the past?

The mean historical Enterprise Value of Sangamo Therapeutics, Inc. over the last ten years is 841.31M. The current 487.19M Enterprise Value has changed 5.69% with respect to the historical average. Over the past ten years (40 quarters), SGMO's Enterprise Value was at its highest in in the December 2020 quarter at 2.12B. The Enterprise Value was at its lowest in in the June 2024 quarter at 68.61M.

Quarterly (TTM)
Annual

Average

841.31M

Median

927.92M

Minimum

87.68M

Maximum

2.01B

Sangamo Therapeutics, Inc. (SGMO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sangamo Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 537.08%

Maximum Annual Enterprise Value = 2.01B

Minimum Annual Increase = -79.48%

Minimum Annual Enterprise Value = 87.68M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202387.68M-79.48%
2022427.31M-55.18%
2021953.47M-52.54%
20202.01B122.62%
2019902.37M-9.78%
20181.00B-20.34%
20171.26B537.08%
2016197.07M-65.27%
2015567.40M-44.01%
20141.01B32.07%

Sangamo Therapeutics, Inc. (SGMO) Average Enterprise Value

How has SGMO Enterprise Value performed in the past?

The current Enterprise Value of Sangamo Therapeutics, Inc. (SGMO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

489.48M

5-year avg

875.93M

10-year avg

841.31M

Sangamo Therapeutics, Inc. (SGMO) Enterprise Value vs. Peers

How is SGMO’s Enterprise Value compared to its peers?

Sangamo Therapeutics, Inc.’s Enterprise Value is greater than Editas Medicine, Inc. (45.84M), less than Intellia Therapeutics, Inc. (1.21B), greater than bluebird bio, Inc. (372.22M), less than Alnylam Pharmaceuticals, Inc. (31.45B), less than ImmunoGen, Inc. (8.19B),

Build a custom stock screener for Sangamo Therapeutics, Inc. (SGMO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sangamo Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sangamo Therapeutics, Inc. (SGMO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sangamo Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Sangamo Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Sangamo Therapeutics, Inc. (SGMO)?

What is the 3-year average Enterprise Value for Sangamo Therapeutics, Inc. (SGMO)?

What is the 5-year average Enterprise Value for Sangamo Therapeutics, Inc. (SGMO)?

How does the current Enterprise Value for Sangamo Therapeutics, Inc. (SGMO) compare to its historical average?